Global Myasthenia Gravis Disease Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

August 2018 | 118 pages | ID: G611A2DCD67GEN
GlobalInfoResearch

Abstracts

Myasthenia gravis (MG) is a long-term neuromuscular disease that leads to varying degrees of skeletal muscle weakness. The most commonly affected muscles are those of the eyes, face, and swallowing. It can result in double vision, drooping eyelids, trouble talking, and trouble walking. Onset can be sudden. Those affected often have a large thymus gland or develop a thymoma.

SCOPE OF THE REPORT:

This report studies the Myasthenia Gravis Disease market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Myasthenia Gravis Disease market by product type and applications/end industries.
Myasthenia gravis is generally treated with medications known as acetylcholinesterase inhibitors such as neostigmineand pyridostigmine. Immunosuppressants, such as prednisone or azathioprine, may also be used. The surgical removal of the thymus gland may improve symptoms in certain cases. Plasmapheresis and high dose intravenous immunoglobulin may be used during sudden flares of the condition. If the breathing muscles become significantly weak, mechanical ventilation may be required.
The global Myasthenia Gravis Disease market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Myasthenia Gravis Disease.

Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

Market Segment by Companies, this report covers

• Valeant Pharmaceuticals
• Sun Pharmaceuticals Industries
• Novartis Pharmaceuticals
• Teva Pharmaceutical Industries
• Cipla
• Roche
• Apotex Corporation
• Pfizer
• Bristol-Myers And Company

Market Segment by Regions, regional analysis covers

• North America (United States, Canada and Mexico)
• Europe (Germany, France, UK, Russia and Italy)
• Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
• South America (Brazil, Argentina, Colombia)
• Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

• Imaging
• Blood Tests
• Electrodiagnostic
• Edrophonium Test
• Pulmonary Function Test

Market Segment by Applications, can be divided into

• Hospitals
• Clinics
• Academic Research Institutes

Contents

1 MYASTHENIA GRAVIS DISEASE MARKET OVERVIEW

1.1 Product Overview and Scope of Myasthenia Gravis Disease
1.2 Classification of Myasthenia Gravis Disease by Types
  1.2.1 Global Myasthenia Gravis Disease Revenue Comparison by Types (2017-2023)
  1.2.2 Global Myasthenia Gravis Disease Revenue Market Share by Types in 2017
  1.2.3 Imaging
  1.2.4 Blood Tests
  1.2.5 Electrodiagnostic
  1.2.6 Edrophonium Test
  1.2.7 Pulmonary Function Test
1.3 Global Myasthenia Gravis Disease Market by Application
  1.3.1 Global Myasthenia Gravis Disease Market Size and Market Share Comparison by Applications (2013-2023)
  1.3.2 Hospitals
  1.3.3 Clinics
  1.3.4 Academic Research Institutes
1.4 Global Myasthenia Gravis Disease Market by Regions
  1.4.1 Global Myasthenia Gravis Disease Market Size (Million USD) Comparison by Regions (2013-2023)
  1.4.1 North America (USA, Canada and Mexico) Myasthenia Gravis Disease Status and Prospect (2013-2023)
  1.4.2 Europe (Germany, France, UK, Russia and Italy) Myasthenia Gravis Disease Status and Prospect (2013-2023)
  1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Myasthenia Gravis Disease Status and Prospect (2013-2023)
  1.4.4 South America (Brazil, Argentina, Colombia) Myasthenia Gravis Disease Status and Prospect (2013-2023)
  1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Myasthenia Gravis Disease Status and Prospect (2013-2023)
1.5 Global Market Size of Myasthenia Gravis Disease (2013-2023)

2 MANUFACTURERS PROFILES

2.1 Valeant Pharmaceuticals
  2.1.1 Business Overview
  2.1.2 Myasthenia Gravis Disease Type and Applications
    2.1.2.1 Product A
    2.1.2.2 Product B
  2.1.3 Valeant Pharmaceuticals Myasthenia Gravis Disease Revenue, Gross Margin and Market Share (2016-2017)
2.2 Sun Pharmaceuticals Industries
  2.2.1 Business Overview
  2.2.2 Myasthenia Gravis Disease Type and Applications
    2.2.2.1 Product A
    2.2.2.2 Product B
  2.2.3 Sun Pharmaceuticals Industries Myasthenia Gravis Disease Revenue, Gross Margin and Market Share (2016-2017)
2.3 Novartis Pharmaceuticals
  2.3.1 Business Overview
  2.3.2 Myasthenia Gravis Disease Type and Applications
    2.3.2.1 Product A
    2.3.2.2 Product B
  2.3.3 Novartis Pharmaceuticals Myasthenia Gravis Disease Revenue, Gross Margin and Market Share (2016-2017)
2.4 Teva Pharmaceutical Industries
  2.4.1 Business Overview
  2.4.2 Myasthenia Gravis Disease Type and Applications
    2.4.2.1 Product A
    2.4.2.2 Product B
  2.4.3 Teva Pharmaceutical Industries Myasthenia Gravis Disease Revenue, Gross Margin and Market Share (2016-2017)
2.5 Cipla
  2.5.1 Business Overview
  2.5.2 Myasthenia Gravis Disease Type and Applications
    2.5.2.1 Product A
    2.5.2.2 Product B
  2.5.3 Cipla Myasthenia Gravis Disease Revenue, Gross Margin and Market Share (2016-2017)
2.6 Roche
  2.6.1 Business Overview
  2.6.2 Myasthenia Gravis Disease Type and Applications
    2.6.2.1 Product A
    2.6.2.2 Product B
  2.6.3 Roche Myasthenia Gravis Disease Revenue, Gross Margin and Market Share (2016-2017)
2.7 Apotex Corporation
  2.7.1 Business Overview
  2.7.2 Myasthenia Gravis Disease Type and Applications
    2.7.2.1 Product A
    2.7.2.2 Product B
  2.7.3 Apotex Corporation Myasthenia Gravis Disease Revenue, Gross Margin and Market Share (2016-2017)
2.8 Pfizer
  2.8.1 Business Overview
  2.8.2 Myasthenia Gravis Disease Type and Applications
    2.8.2.1 Product A
    2.8.2.2 Product B
  2.8.3 Pfizer Myasthenia Gravis Disease Revenue, Gross Margin and Market Share (2016-2017)
2.9 Bristol-Myers And Company
  2.9.1 Business Overview
  2.9.2 Myasthenia Gravis Disease Type and Applications
    2.9.2.1 Product A
    2.9.2.2 Product B
  2.9.3 Bristol-Myers And Company Myasthenia Gravis Disease Revenue, Gross Margin and Market Share (2016-2017)

3 GLOBAL MYASTHENIA GRAVIS DISEASE MARKET COMPETITION, BY PLAYERS

3.1 Global Myasthenia Gravis Disease Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
  3.2.1 Top 5 Myasthenia Gravis Disease Players Market Share
  3.2.2 Top 10 Myasthenia Gravis Disease Players Market Share
3.3 Market Competition Trend

4 GLOBAL MYASTHENIA GRAVIS DISEASE MARKET SIZE BY REGIONS

4.1 Global Myasthenia Gravis Disease Revenue and Market Share by Regions
4.2 North America Myasthenia Gravis Disease Revenue and Growth Rate (2013-2018)
4.3 Europe Myasthenia Gravis Disease Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Myasthenia Gravis Disease Revenue and Growth Rate (2013-2018)
4.5 South America Myasthenia Gravis Disease Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Myasthenia Gravis Disease Revenue and Growth Rate (2013-2018)

5 NORTH AMERICA MYASTHENIA GRAVIS DISEASE REVENUE BY COUNTRIES

5.1 North America Myasthenia Gravis Disease Revenue by Countries (2013-2018)
5.2 USA Myasthenia Gravis Disease Revenue and Growth Rate (2013-2018)
5.3 Canada Myasthenia Gravis Disease Revenue and Growth Rate (2013-2018)
5.4 Mexico Myasthenia Gravis Disease Revenue and Growth Rate (2013-2018)

6 EUROPE MYASTHENIA GRAVIS DISEASE REVENUE BY COUNTRIES

6.1 Europe Myasthenia Gravis Disease Revenue by Countries (2013-2018)
6.2 Germany Myasthenia Gravis Disease Revenue and Growth Rate (2013-2018)
6.3 UK Myasthenia Gravis Disease Revenue and Growth Rate (2013-2018)
6.4 France Myasthenia Gravis Disease Revenue and Growth Rate (2013-2018)
6.5 Russia Myasthenia Gravis Disease Revenue and Growth Rate (2013-2018)
6.6 Italy Myasthenia Gravis Disease Revenue and Growth Rate (2013-2018)

7 ASIA-PACIFIC MYASTHENIA GRAVIS DISEASE REVENUE BY COUNTRIES

7.1 Asia-Pacific Myasthenia Gravis Disease Revenue by Countries (2013-2018)
7.2 China Myasthenia Gravis Disease Revenue and Growth Rate (2013-2018)
7.3 Japan Myasthenia Gravis Disease Revenue and Growth Rate (2013-2018)
7.4 Korea Myasthenia Gravis Disease Revenue and Growth Rate (2013-2018)
7.5 India Myasthenia Gravis Disease Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Myasthenia Gravis Disease Revenue and Growth Rate (2013-2018)

8 SOUTH AMERICA MYASTHENIA GRAVIS DISEASE REVENUE BY COUNTRIES

8.1 South America Myasthenia Gravis Disease Revenue by Countries (2013-2018)
8.2 Brazil Myasthenia Gravis Disease Revenue and Growth Rate (2013-2018)
8.3 Argentina Myasthenia Gravis Disease Revenue and Growth Rate (2013-2018)
8.4 Colombia Myasthenia Gravis Disease Revenue and Growth Rate (2013-2018)

9 MIDDLE EAST AND AFRICA REVENUE MYASTHENIA GRAVIS DISEASE BY COUNTRIES

9.1 Middle East and Africa Myasthenia Gravis Disease Revenue by Countries (2013-2018)
9.2 Saudi Arabia Myasthenia Gravis Disease Revenue and Growth Rate (2013-2018)
9.3 UAE Myasthenia Gravis Disease Revenue and Growth Rate (2013-2018)
9.4 Egypt Myasthenia Gravis Disease Revenue and Growth Rate (2013-2018)
9.5 Nigeria Myasthenia Gravis Disease Revenue and Growth Rate (2013-2018)
9.6 South Africa Myasthenia Gravis Disease Revenue and Growth Rate (2013-2018)

10 GLOBAL MYASTHENIA GRAVIS DISEASE MARKET SEGMENT BY TYPE

10.1 Global Myasthenia Gravis Disease Revenue and Market Share by Type (2013-2018)
10.2 Global Myasthenia Gravis Disease Market Forecast by Type (2018-2023)
10.3 Imaging Revenue Growth Rate (2013-2023)
10.4 Blood Tests Revenue Growth Rate (2013-2023)
10.5 Electrodiagnostic Revenue Growth Rate (2013-2023)
10.6 Edrophonium Test Revenue Growth Rate (2013-2023)
10.7 Pulmonary Function Test Revenue Growth Rate (2013-2023)

11 GLOBAL MYASTHENIA GRAVIS DISEASE MARKET SEGMENT BY APPLICATION

11.1 Global Myasthenia Gravis Disease Revenue Market Share by Application (2013-2018)
11.2 Myasthenia Gravis Disease Market Forecast by Application (2018-2023)
11.3 Hospitals Revenue Growth (2013-2018)
11.4 Clinics Revenue Growth (2013-2018)
11.5 Academic Research Institutes Revenue Growth (2013-2018)

12 GLOBAL MYASTHENIA GRAVIS DISEASE MARKET SIZE FORECAST (2018-2023)

12.1 Global Myasthenia Gravis Disease Market Size Forecast (2018-2023)
12.2 Global Myasthenia Gravis Disease Market Forecast by Regions (2018-2023)
12.3 North America Myasthenia Gravis Disease Revenue Market Forecast (2018-2023)
12.4 Europe Myasthenia Gravis Disease Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Myasthenia Gravis Disease Revenue Market Forecast (2018-2023)
12.6 South America Myasthenia Gravis Disease Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Myasthenia Gravis Disease Revenue Market Forecast (2018-2023)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

14.1 Methodology
14.2 Data Source

List Of Tables

LIST OF TABLES AND FIGURES

Figure Myasthenia Gravis Disease Picture
Table Product Specifications of Myasthenia Gravis Disease
Table Global Myasthenia Gravis Disease and Revenue (Million USD) Market Split by Product Type
Figure Global Myasthenia Gravis Disease Revenue Market Share by Types in 2017
Figure Imaging Picture
Figure Blood Tests Picture
Figure Electrodiagnostic Picture
Figure Edrophonium Test Picture
Figure Pulmonary Function Test Picture
Table Global Myasthenia Gravis Disease Revenue (Million USD) by Application (2013-2023)
Figure Myasthenia Gravis Disease Revenue Market Share by Applications in 2017
Figure Hospitals Picture
Figure Clinics Picture
Figure Academic Research Institutes Picture
Table Global Market Myasthenia Gravis Disease Revenue (Million USD) Comparison by Regions 2013-2023
Figure North America Myasthenia Gravis Disease Revenue (Million USD) and Growth Rate (2013-2023)
Figure Europe Myasthenia Gravis Disease Revenue (Million USD) and Growth Rate (2013-2023)
Figure Asia-Pacific Myasthenia Gravis Disease Revenue (Million USD) and Growth Rate (2013-2023)
Figure South America Myasthenia Gravis Disease Revenue (Million USD) and Growth Rate (2013-2023)
Figure Middle East and Africa Myasthenia Gravis Disease Revenue (Million USD) and Growth Rate (2013-2023)
Figure Global Myasthenia Gravis Disease Revenue (Million USD) and Growth Rate (2013-2023)
Table Valeant Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Valeant Pharmaceuticals Myasthenia Gravis Disease Type and Applications
Table Valeant Pharmaceuticals Myasthenia Gravis Disease Revenue, Gross Margin and Market Share (2016-2017)
Table Sun Pharmaceuticals Industries Basic Information, Manufacturing Base and Competitors
Table Sun Pharmaceuticals Industries Myasthenia Gravis Disease Type and Applications
Table Sun Pharmaceuticals Industries Myasthenia Gravis Disease Revenue, Gross Margin and Market Share (2016-2017)
Table Novartis Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Novartis Pharmaceuticals Myasthenia Gravis Disease Type and Applications
Table Novartis Pharmaceuticals Myasthenia Gravis Disease Revenue, Gross Margin and Market Share (2016-2017)
Table Teva Pharmaceutical Industries Basic Information, Manufacturing Base and Competitors
Table Teva Pharmaceutical Industries Myasthenia Gravis Disease Type and Applications
Table Teva Pharmaceutical Industries Myasthenia Gravis Disease Revenue, Gross Margin and Market Share (2016-2017)
Table Cipla Basic Information, Manufacturing Base and Competitors
Table Cipla Myasthenia Gravis Disease Type and Applications
Table Cipla Myasthenia Gravis Disease Revenue, Gross Margin and Market Share (2016-2017)
Table Roche Basic Information, Manufacturing Base and Competitors
Table Roche Myasthenia Gravis Disease Type and Applications
Table Roche Myasthenia Gravis Disease Revenue, Gross Margin and Market Share (2016-2017)
Table Apotex Corporation Basic Information, Manufacturing Base and Competitors
Table Apotex Corporation Myasthenia Gravis Disease Type and Applications
Table Apotex Corporation Myasthenia Gravis Disease Revenue, Gross Margin and Market Share (2016-2017)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Myasthenia Gravis Disease Type and Applications
Table Pfizer Myasthenia Gravis Disease Revenue, Gross Margin and Market Share (2016-2017)
Table Bristol-Myers And Company Basic Information, Manufacturing Base and Competitors
Table Bristol-Myers And Company Myasthenia Gravis Disease Type and Applications
Table Bristol-Myers And Company Myasthenia Gravis Disease Revenue, Gross Margin and Market Share (2016-2017)
Table Global Myasthenia Gravis Disease Revenue (Million USD) by Players (2013-2018)
Table Global Myasthenia Gravis Disease Revenue Share by Players (2013-2018)
Figure Global Myasthenia Gravis Disease Revenue Share by Players in 2016
Figure Global Myasthenia Gravis Disease Revenue Share by Players in 2017
Figure Global Top 5 Players Myasthenia Gravis Disease Revenue Market Share in 2017
Figure Global Top 10 Players Myasthenia Gravis Disease Revenue Market Share in 2017
Figure Global Myasthenia Gravis Disease Revenue (Million USD) and Growth Rate (%) (2013-2018)
Table Global Myasthenia Gravis Disease Revenue (Million USD) by Regions (2013-2018)
Table Global Myasthenia Gravis Disease Revenue Market Share by Regions (2013-2018)
Figure Global Myasthenia Gravis Disease Revenue Market Share by Regions (2013-2018)
Figure Global Myasthenia Gravis Disease Revenue Market Share by Regions in 2017
Figure North America Myasthenia Gravis Disease Revenue and Growth Rate (2013-2018)
Figure Europe Myasthenia Gravis Disease Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Myasthenia Gravis Disease Revenue and Growth Rate (2013-2018)
Figure South America Myasthenia Gravis Disease Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Myasthenia Gravis Disease Revenue and Growth Rate (2013-2018)
Table North America Myasthenia Gravis Disease Revenue by Countries (2013-2018)
Table North America Myasthenia Gravis Disease Revenue Market Share by Countries (2013-2018)
Figure North America Myasthenia Gravis Disease Revenue Market Share by Countries (2013-2018)
Figure North America Myasthenia Gravis Disease Revenue Market Share by Countries in 2017
Figure USA Myasthenia Gravis Disease Revenue and Growth Rate (2013-2018)
Figure Canada Myasthenia Gravis Disease Revenue and Growth Rate (2013-2018)
Figure Mexico Myasthenia Gravis Disease Revenue and Growth Rate (2013-2018)
Table Europe Myasthenia Gravis Disease Revenue (Million USD) by Countries (2013-2018)
Figure Europe Myasthenia Gravis Disease Revenue Market Share by Countries (2013-2018)
Figure Europe Myasthenia Gravis Disease Revenue Market Share by Countries in 2017
Figure Germany Myasthenia Gravis Disease Revenue and Growth Rate (2013-2018)
Figure UK Myasthenia Gravis Disease Revenue and Growth Rate (2013-2018)
Figure France Myasthenia Gravis Disease Revenue and Growth Rate (2013-2018)
Figure Russia Myasthenia Gravis Disease Revenue and Growth Rate (2013-2018)
Figure Italy Myasthenia Gravis Disease Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Myasthenia Gravis Disease Revenue (Million USD) by Countries (2013-2018)
Figure Asia-Pacific Myasthenia Gravis Disease Revenue Market Share by Countries (2013-2018)
Figure Asia-Pacific Myasthenia Gravis Disease Revenue Market Share by Countries in 2017
Figure China Myasthenia Gravis Disease Revenue and Growth Rate (2013-2018)
Figure Japan Myasthenia Gravis Disease Revenue and Growth Rate (2013-2018)
Figure Korea Myasthenia Gravis Disease Revenue and Growth Rate (2013-2018)
Figure India Myasthenia Gravis Disease Revenue and Growth Rate (2013-2018)
Figure Southeast Asia Myasthenia Gravis Disease Revenue and Growth Rate (2013-2018)
Table South America Myasthenia Gravis Disease Revenue by Countries (2013-2018)
Table South America Myasthenia Gravis Disease Revenue Market Share by Countries (2013-2018)
Figure South America Myasthenia Gravis Disease Revenue Market Share by Countries (2013-2018)
Figure South America Myasthenia Gravis Disease Revenue Market Share by Countries in 2017
Figure Brazil Myasthenia Gravis Disease Revenue and Growth Rate (2013-2018)
Figure Argentina Myasthenia Gravis Disease Revenue and Growth Rate (2013-2018)
Figure Colombia Myasthenia Gravis Disease Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Myasthenia Gravis Disease Revenue (Million USD) by Countries (2013-2018)
Table Middle East and Africa Myasthenia Gravis Disease Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Myasthenia Gravis Disease Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Myasthenia Gravis Disease Revenue Market Share by Countries in 2017
Figure Saudi Arabia Myasthenia Gravis Disease Revenue and Growth Rate (2013-2018)
Figure UAE Myasthenia Gravis Disease Revenue and Growth Rate (2013-2018)
Figure Egypt Myasthenia Gravis Disease Revenue and Growth Rate (2013-2018)
Figure Nigeria Myasthenia Gravis Disease Revenue and Growth Rate (2013-2018)
Figure South Africa Myasthenia Gravis Disease Revenue and Growth Rate (2013-2018)
Table Global Myasthenia Gravis Disease Revenue (Million USD) by Type (2013-2018)
Table Global Myasthenia Gravis Disease Revenue Share by Type (2013-2018)
Figure Global Myasthenia Gravis Disease Revenue Share by Type (2013-2018)
Figure Global Myasthenia Gravis Disease Revenue Share by Type in 2017
Table Global Myasthenia Gravis Disease Revenue Forecast by Type (2018-2023)
Figure Global Myasthenia Gravis Disease Market Share Forecast by Type (2018-2023)
Figure Global Imaging Revenue Growth Rate (2013-2018)
Figure Global Blood Tests Revenue Growth Rate (2013-2018)
Figure Global Electrodiagnostic Revenue Growth Rate (2013-2018)
Figure Global Edrophonium Test Revenue Growth Rate (2013-2018)
Figure Global Pulmonary Function Test Revenue Growth Rate (2013-2018)
Table Global Myasthenia Gravis Disease Revenue by Application (2013-2018)
Table Global Myasthenia Gravis Disease Revenue Share by Application (2013-2018)
Figure Global Myasthenia Gravis Disease Revenue Share by Application (2013-2018)
Figure Global Myasthenia Gravis Disease Revenue Share by Application in 2017
Table Global Myasthenia Gravis Disease Revenue Forecast by Application (2018-2023)
Figure Global Myasthenia Gravis Disease Market Share Forecast by Application (2018-2023)
Figure Global Hospitals Revenue Growth Rate (2013-2018)
Figure Global Clinics Revenue Growth Rate (2013-2018)
Figure Global Academic Research Institutes Revenue Growth Rate (2013-2018)
Figure Global Myasthenia Gravis Disease Revenue (Million USD) and Growth Rate Forecast (2018 -2023)
Table Global Myasthenia Gravis Disease Revenue (Million USD) Forecast by Regions (2018-2023)
Figure Global Myasthenia Gravis Disease Revenue Market Share Forecast by Regions (2018-2023)
Figure North America Myasthenia Gravis Disease Revenue Market Forecast (2018-2023)
Figure Europe Myasthenia Gravis Disease Revenue Market Forecast (2018-2023)
Figure Asia-Pacific Myasthenia Gravis Disease Revenue Market Forecast (2018-2023)
Figure South America Myasthenia Gravis Disease Revenue Market Forecast (2018-2023)
Figure Middle East and Africa Myasthenia Gravis Disease Revenue Market Forecast (2018-2023)